Integrating PROs into studies on MASH, also known as NASH, is crucial.
MASH is a debilitating chronic illness that significantly impairs patients’ quality of life, affecting their daily routines, work, and mobility.
- Patient-centric appraisals are needed in the quest for treatments
- Integrating PROs in MASH studies expands insights beyond MASH metrics, and helps understand MASH patients’ concerns
At Kayentis, we have the full capability to run your MASH studies successfully:
- We have extensive experience in MASH and hepatic disorders research
- We offer an enhanced patient-centric eCOA data entry
- We are a key partner to biotech and big pharma companies
Download the case study 👇
